GE HealthCare Technologies Inc (GEHC)

NASDAQ
Currency in USD
72.25
-0.86(-1.18%)
Closed·
After Hours
72.42+0.17(+0.23%)
·
GEHC Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
GEHC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
71.9172.79
52 wk Range
57.6594.80
Key Statistics
Edit
Prev. Close
73.11
Open
72.19
Day's Range
71.91-72.79
52 wk Range
57.65-94.8
Volume
2.98M
Average Volume (3m)
4.84M
1-Year Change
-5.54%
Book Value / Share
20.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GEHC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
87.40
Upside
+20.97%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry
Show more

GE HealthCare Technologies Inc Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue reached $4.8B with 4% organic growth; adjusted EPS up 12% to $1.01; stock rose 4.52% post-earnings
  • Record backlog of $20.6B; strong demand in US and Europe, but mid-single-digit decline expected in China for H1 2025
  • FY2025 guidance: 2-3% organic revenue growth, adjusted EBIT margin 14.2-14.4%, adjusted EPS $3.90-$4.10
  • $0.85 per share tariff impact projected for 2025, with reduction expected in 2026; company focused on mitigating effects
  • Analysts maintain bullish stance; stock trading below Fair Value per InvestingPro analysis, suggesting potential opportunity
Last Updated: 30/04/2025, 14:40
Read Full Transcript

Compare GEHC to Peers and Sector

Metrics to compare
GEHC
Peers
Sector
Relationship
P/E Ratio
15.2x28.4x−0.5x
PEG Ratio
0.390.120.00
Price/Book
3.6x2.3x2.6x
Price / LTM Sales
1.7x2.2x3.1x
Upside (Analyst Target)
18.3%56.5%51.1%
Fair Value Upside
Unlock−5.2%8.9%Unlock

Analyst Ratings

16 Buy
5 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 87.40
(+20.97% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.78%
Dividend Yield
0.19%
Industry Median 0.75%
Annualised payout
0.14
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
1.23 / 1.07
Revenue / Forecast
4.78B / 4.998B
EPS Revisions
Last 90 days

GEHC Income Statement

People Also Watch

364.49
APP
-4.23%
51.02
ON
-3.70%
67.19
MRVL
-3.52%
819.36
LLY
+0.90%
141.97
NVDA
-2.09%

FAQ

What Stock Exchange Does GE HealthCare Trade On?

GE HealthCare is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for GE HealthCare?

The stock symbol for GE HealthCare is "GEHC."

What Is the GE HealthCare Market Cap?

As of today, GE HealthCare market cap is 33.08B.

What Is GE HealthCare's Earnings Per Share (TTM)?

The GE HealthCare EPS (TTM) is 4.78.

From a Technical Analysis Perspective, Is GEHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has GE HealthCare Stock Split?

GE HealthCare has split 0 times.

How Many Employees Does GE HealthCare Have?

GE HealthCare has 53000 employees.

What is the current trading status of GE HealthCare (GEHC)?

As of 16 Jun 2025, GE HealthCare (GEHC) is trading at a price of 72.25, with a previous close of 73.11. The stock has fluctuated within a day range of 71.91 to 72.79, while its 52-week range spans from 57.65 to 94.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.